Stock Market & Financial Investment News

News Breaks January 15, 2013 08:02 EDT REGN Regeneron price target raised to $205 from $176 at RW Baird Baird raised its price target on Regeneron following the its recent bullish Eylea survey which indicated the drug's uptake trajectory remains strong. The firm believes the EU roll-out of Eylea and late stage pipeline will push the share price to its price target. Shares are Outperform rated. News For REGN From The Last 14 Days Check below for free stories on REGN the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 17, 2013 10:07 EDT REGN On The Fly: Analyst Initiation Summary Subscribe for More Information 07:16 EDT REGN Regeneron initiated with a Neutral at UBS Subscribe for More Information 06:33 EDT REGN American Thoracic Society to hold a conference Subscribe for More Information May 15, 2013 05:39 EDT REGN Sanofi, Regeneron announce patient enrollment in two Phase 3 trials Subscribe for More Information May 14, 2013 07:34 EDT REGN Regeneron outlook positive, says RBC Capital Subscribe for More Information May 10, 2013 07:24 EDT REGN Credit Suisse to host a conference Subscribe for More Information May 6, 2013 09:02 EDT REGN Regeneron price target raised to $314 from $200 at Roth Capital Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.